Recasting the lowly formulary
Smith, S.D.
Minnesota Medicine 89(4): 28-29; 44
2006
ISSN/ISBN: 0026-556X PMID: 16681278 Document Number: 602323
Document emailed within 1 workday
Related Documents
Wang, Y.R.; Pauly, M.V. 2005: Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors Managed Care Interface 18(8): 39-451988: SMF focus. The "lowly" condom tops the charts Social Marketing Forum 1988(14): 3
Miller, E.C. 1993: Recasting Florida's insanity defense. two modest proposals Journal of the Florida Medical Association 80(10): 684-688
Čairović, A.; Maksimović, V.; Radović, K.; Djurišić, S. 2016: The effect of recasting on biological properties of Ni-Cr dental alloy Srpski Arhiv Za Celokupno Lekarstvo 144(11-12): 574-579
Zeng, J.; Lin, W.; Liang, K.; Chen, F.; Guo, Y.; Tang, L.; He, H.; Wang, J.; Liang, Y. 2003: Molecular responses of rice (Oryza sativa L.) to the stress of lowly enhanced UV-B radiation Ying Yong Sheng Tai Xue Bao 14(6): 941-944
Martucci, H.J. 1987: Different approach to the formulary needed American Journal of Hospital Pharmacy 44(5): 1026
Reilly, P.; Annesley, E. 1992: Why bother with a practice formulary? Practitioner 236(1516): 740-742
Navarro, R.P. 1999: Raising the bar in the formulary decision process Managed Care Interface 12(7): 51; 54
DiPiro, J.T.; Steele, J.C. 1987: Rational formulary selection of antimicrobials American Journal of Hospital Pharmacy 44(1): 74
Ford, D.B.; Bergerson, S.L.; Henderson, P.; Murphy, J.; Peter, J. 1989: Establishing an enteral product formulary Journal of the American Dietetic Association 89(5): 681-683
Berod, T.; Vetel, J.M.; Sauvageon, A. 1990: Compliance with a formulary for geriatric patients American Journal of Hospital Pharmacy 47(8): 1751-1752
Montanari, L. 1979: Fifth supplement to the United States Pharmacopoeia XIX and National Formulary XIV Bollettino Chimico Farmaceutico 118(10): 585-593
Lilja, J. 1979: Drug product selection by formulary committees in Sweden American Journal of Hospital Pharmacy 36(8): 1042 1044
Abourjaily, P.; Gouveia, W.A.; Selker, H.P.; Zucker, D.R. 2005: Evaluating the nondrug costs of formulary coverage restrictions Managed Care 14(8): 50-7 62
Smith, E.B.; Hope, S.M.; Halstead, S.K.; Ford, W.M. 1990: Integration of formulary systems with centralized pharmaceutical procurement Hospital Formulary 25(2): 193-196; 198
Andriole, V.T.; Ryan, J.L. 1982: An approach to formulary consideration of antimicrobial agents: the tetracyclines Hospital Formulary 17(7): 965-968
Reinke, T. 2012: New diabetes medications drive up costs and stymie formulary design Managed Care 21(4): 16-18
Richerson, M.A.; Ambrose, P.G.; Quintiliani, R.; Nightingale, C.H. 1998: Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem Connecticut Medicine 62(3): 165-169
Owens, R.C.; Ambrose, P.G.; Quintiliani, R. 1997: Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationale Connecticut Medicine 61(4): 225-227
Smith, M.C.; Maclayton, D.W. 1977: The effect of closing a Medicaid formulary on the prescription of analgesic drugs Hospital Formulary 12(1): 36-38; 41